Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2007
11/07/2007CN101068779A 9,10-secopregnane derivative and medicine
11/07/2007CN101067135A Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066425A Chinese medicine prepn for treating ungual mycosis
11/07/2007CN101066423A Chinese medicine for treating cutaneous pruritus
11/07/2007CN101066397A Acne eliminating health product
11/07/2007CN101066392A Externally applied medicine for dispelling damp, eliminating swelling and relieving pain and its prepn
11/07/2007CN101066377A Chinese medicine prepn for treating itchthyosis
11/07/2007CN101066372A Acne eliminating health product
11/07/2007CN101066363A Acne eliminating health product
11/07/2007CN101066340A Compound externally applied tetrodotoxin ointment and its prepn
11/07/2007CN101066338A Chinese medicine for treating wheal during menstruation
11/07/2007CN101066320A Chinese medicine composition for treating wheal during menstruation
11/07/2007CN101066318A Acne eliminating health product
11/07/2007CN101066310A Health product for eliminating chloasma
11/07/2007CN101066307A Burn treating medicine powder and its prepn
11/07/2007CN101066305A Reducing Chinese medicine liquid for treating wound and acne without scar and pigment left and its prepn
11/07/2007CN101066301A Health product for eliminating chloasma
11/07/2007CN101066296A Chinese medicine ointment for treating burns and scalds and its prepn
11/07/2007CN101066287A Skin repairing dahurian angelica powder
11/07/2007CN101066285A Application of aweto prepn in preparing medicine for treating skin diseases
11/07/2007CN101066281A Self first aid medicine for treating injury
11/07/2007CN101066277A Jelly for treating skin wound and its prepn process
11/07/2007CN101066274A Prepn process of double salt potassium D-aminogluconate sulfate
11/07/2007CN101066256A Soft capsule containing common lamiophlomis root extract
11/07/2007CN101066246A Bailianhu medicine powder
11/07/2007CN101066130A Face nursing health food
11/07/2007CN101066129A Acne eliminating health product
11/07/2007CN101066128A Acne eliminating health product
11/07/2007CN101066127A Acne eliminating health product
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347176C Novel dithiolopyrrolones with therapeutic activity
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346814C Powder for curing muscle ulceration and process for preparing the same
11/07/2007CN100346795C Method for manufacturing medical health-care beauty article
11/07/2007CN100346767C Composite powders and skin preparations for external use containing the same
11/06/2007US7291734 N-(4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridin-2-yl)sulfonamides, e.g., 2-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]-4-trifluoromethyl-benzamide; steroid sulfatase inhibitors used to treat diseases including acne
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/02/2007CA2587002A1 Stem cells derived from bone marrow for tissue regeneration
11/01/2007WO2007124433A1 Hemostatic compositions and methods for controlling bleeding
11/01/2007WO2007123044A1 Licorice polyphenol preparation
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122402A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007104898A3 Method for reducing the odour caused by lipoamino acids in topical cosmetic and/or pharmaceutical formulations
11/01/2007WO2007075750A3 Compositions containing cotinus coggygria extract and use thereof in treating wounds
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007059905A9 Thienopyrimidines treating inflammatory diseases
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2006092507A8 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/01/2007WO2006083182A9 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255254 Cell delivery system
11/01/2007US20070255238 Hemostatic Polymer Useful for Rapid Blood Coagulation and Hemostasis
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070254953 Topical compositions of urea and ammonium lactate
11/01/2007US20070254946 Hair Growth Stimulants
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007US20070254855 Method for the treatment of acne
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254052 Substances capable of potentiating laminin 5 productivity in epidermal cells and their use
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007US20070253944 Use of creatine or creatine compounds for skin preservation
11/01/2007US20070253943 Compositions for Topical Treatment
11/01/2007US20070253940 Composition Comprising Platelet-Rich Plasma
11/01/2007US20070253939 Cell delivery system
11/01/2007US20070253912 Process for the preparation of micronised collagen, and its therapeutic applications
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649522A1 Medicaments
11/01/2007CA2649514A1 Licorice polyphenol preparation
10/2007
10/31/2007EP1849487A2 Film-forming compositions and methods
10/31/2007EP1849456A1 Use of a 4-aminopiperidine derivative as agent for inducing and/or stimulating the growth of keratin fibres and/or preventing their loss
10/31/2007EP1849455A1 Use of a 4-aminopiperidine derivative as agent for inducing and/or stimulating the growth of keratin fibres and/or preventing their loss
10/31/2007EP1848427A1 Use of estrogen receptor-b selective agonists for radiation-or chemotherapy-induced mucosistis and radiation cystitis
10/31/2007EP1771180B1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
10/31/2007EP1587505A4 Wound and skin care compositions
10/31/2007EP1581252A4 Wound and skin care products
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/31/2007EP1294802B1 Polysaccharide based gel
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 1065